These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21328546)

  • 21. Processing of plasmid DNA with ColE1-like replication origin.
    Wang Z; Yuan Z; Hengge UR
    Plasmid; 2004 May; 51(3):149-61. PubMed ID: 15109822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression.
    Carnes AE; Luke JM; Vincent JM; Schukar A; Anderson S; Hodgson CP; Williams JA
    Biotechnol Bioeng; 2011 Feb; 108(2):354-63. PubMed ID: 20830679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a 24-kb plasmid pCGR2 newly isolated from Corynebacterium glutamicum.
    Tsuchida Y; Kimura S; Suzuki N; Inui M; Yukawa H
    Appl Microbiol Biotechnol; 2010 Aug; 87(5):1855-66. PubMed ID: 20552356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA vaccination for cancer treatment.
    Spooner RA; Deonarain MP; Epenetos AA
    Gene Ther; 1995 May; 2(3):173-80. PubMed ID: 7614247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.
    Cai Y; Rodriguez S; Rameswaran R; Draghia-Akli R; Juba RJ; Hebel H
    Vaccine; 2010 Feb; 28(8):2046-52. PubMed ID: 19896448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques.
    Schadeck EB; Sidhu M; Egan MA; Chong SY; Piacente P; Masood A; Garcia-Hand D; Cappello S; Roopchand V; Megati S; Quiroz J; Boyer JD; Felber BK; Pavlakis GN; Weiner DB; Eldridge JH; Israel ZR
    Vaccine; 2006 May; 24(21):4677-87. PubMed ID: 16288822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines.
    Sullivan SM; Doukas J; Hartikka J; Smith L; Rolland A
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1433-46. PubMed ID: 21118032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of plasmid DNA for pharmaceutical use.
    Voss C
    Biotechnol Annu Rev; 2007; 13():201-22. PubMed ID: 17875478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of pCOR plasmid copy number for pharmaceutical applications.
    Soubrier F; Laborderie B; Cameron B
    Appl Microbiol Biotechnol; 2005 Mar; 66(6):683-8. PubMed ID: 15349701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
    Honma M
    Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice.
    Egan MA; Megati S; Roopchand V; Garcia-Hand D; Luckay A; Chong SY; Rosati M; Sackitey S; Weiner DB; Felber BK; Pavlakis GN; Israel ZR; Eldridge JH; Sidhu MK
    Vaccine; 2006 May; 24(21):4510-23. PubMed ID: 16140439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography.
    Sousa F; Prazeres DM; Queiroz JA
    J Gene Med; 2009 Jan; 11(1):79-88. PubMed ID: 19021136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.
    Li J; Makrigiorgos GM
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):427-32. PubMed ID: 19290875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis and use of endogenous nuclease activities in Escherichia coli lysates during the primary isolation of plasmids for gene therapy.
    Monteiro GA; Ferreira GN; Cabral JM; Prazeres DM
    Biotechnol Bioeng; 1999; 66(3):189-94. PubMed ID: 10577473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of real-time polymerase chain reaction and hybridization assays for the detection of Escherichia coli genomic DNA in process samples and pharmaceutical-grade plasmid DNA products.
    Martins SA; Prazeres DM; Cabral JM; Monteiro GA
    Anal Biochem; 2003 Nov; 322(1):127-9. PubMed ID: 14705789
    [No Abstract]   [Full Text] [Related]  

  • 36. A plasmid DNA immunogen expressing fifteen protein antigens and complex virus-like particles (VLP+) mimicking naturally occurring HIV.
    Somogyi E; Xu J; Gudics A; Tóth J; Kovács AL; Lori F; Lisziewicz J
    Vaccine; 2011 Jan; 29(4):744-53. PubMed ID: 21109034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA insertions in the 'silent' regions of the 2 microns plasmid of Saccharomyces cerevisiae influence plasmid stability.
    Bijovet JF; van der Zanden AL; Goosen N; Brouwer J; van de Putte P
    Yeast; 1991; 7(4):347-56. PubMed ID: 1872027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccines.
    Ongkudon CM; Ho J; Danquah MK
    Crit Rev Biotechnol; 2011 Mar; 31(1):32-52. PubMed ID: 20879832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and use of flow cytometry optimized plasmid-sensor strains.
    Bahl MI; Oregaard G; Sørensen SJ; Hansen LH
    Methods Mol Biol; 2009; 532():257-68. PubMed ID: 19271190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies.
    Budker VG; Subbotin VM; Budker T; Sebestyén MG; Zhang G; Wolff JA
    J Gene Med; 2006 Jul; 8(7):874-88. PubMed ID: 16718734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.